In AD patients, interleukins (IL-21 and IL-22, etc.)generated by Th17 cells, as well as transcription factors (RORγ, etc.)involved in Th17 cell growth, are significantly increased (Saresella et al., 2011). The gene discussed is IL22; the disease is Alzheimer disease.